NBTY Announces Sales Results For January 2004
10 2월 2004 - 1:30AM
PR Newswire (US)
NBTY Announces Sales Results For January 2004 BOHEMIA, N.Y., Feb. 9
/PRNewswire-FirstCall/ -- NBTY, Inc. (http://www.nbty.com/), a
leading manufacturer and marketer of nutritional supplements, today
announced its sales results for the month of January 2004 in
conjunction with an analyst meeting taking place today at the
Company's offices on Long Island, New York. For the month of
January 2004, sales increased 64% to $150 million from $91 million
for the month of January 2003, an increase of $59 million. Sales
results by segment are as follows: SALES (Unaudited) FOR THE MONTH
OF JANUARY (In Millions) 2004 2003 % Increase Wholesale/ US
Nutrition $66 $25 163% US Retail / Vitamin World $20 $18 9%
European Retail / Holland & Barrett / GNC UK $42 $30 40% Direct
Response / Puritan's Pride $22 $18 23% Total $150 $91 64% ABOUT
NBTY NBTY is a leading vertically integrated manufacturer and
distributor of a broad line of high-quality, value-priced
nutritional supplements in the United States and throughout the
world. The Company markets approximately 1,500 products under
several brands, including Nature's Bounty(R), Vitamin World(R),
Puritan's Pride(R), Holland & Barrett(R), Rexall(R),
Sundown(R), MET-Rx(R), WORLDWIDE Sport Nutrition(R), American
Health(R), GNC (UK)(R) and DeTuinen(R). This release contains
certain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995 with respect to
our financial condition, results of operations and business. All of
these forward-looking statements, which can be identified by the
use of terminology such as "subject to," "believe," "expects,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy which, although believed to be reasonable,
are inherently uncertain. Factors which may materially affect such
forward-looking statements include: (i) slow or negative growth in
the nutritional supplement industry; (ii) interruption of business
or negative impact on sales and earnings due to actsof war,
terrorism, bio-terrorism, civil unrest or disruption of mail
service; (iii) adverse publicity regarding nutritional supplements;
(iv) inability to retain customers of companies (or mailing lists)
recently acquired; (v) increased competition; (vi) increased costs;
(vii) loss or retirement of key members of management; (viii)
increases in the cost of borrowings and unavailability of
additional debt or equity capital; (ix) unavailability of, or
inability to consummate, advantageous acquisitions in the future,
including those that may be subject to bankruptcy approval or the
inability of NBTY to integrate acquisitions into the mainstream of
its business; (x) changes in general worldwide economic and
political conditions in the markets in which NBTY may compete from
time to time; (xi) the inability of NBTY to gain and/or hold market
share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical
areas; (xiii) the inability of NBTY to obtain and/or renew
insurance; (xiv) exposure to and expense of defending and
resolving, product liability claims and other litigation; (xv) the
ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manageits retail, wholesale,
manufacturing and other operations efficiently; (xvii) consumer
acceptance of NBTY's products; (xviii) the inability of NBTY to
renew leases on its retail locations; (xix) inability of NBTY's
retail stores to attain or maintain profitability; (xx) the absence
of clinical trials for many of NBTY's products; (xxi) sales and
earnings volatility and/or trends; (xxii) the efficacy of NBTY's
Internet and on-line sales and marketing; (xxiii) fluctuations in
foreign currencies, including the British Pound; (xxiv)
import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in
opening, new retail locations; (xxvi) introduction of new federal,
state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the
banning of products) and more particularly the Food Supplements
Directive and the Traditional Herbal Medicinal Products Directive
in Europe; (xxvii) themix of NBTY's products and the profit margins
thereon; (xxviii) the availability and pricing of raw materials;
(xxix) risk factors discussed in NBTY's filings with the U.S.
Securities and Exchange Commission; and (xxx) other factors beyond
NBTY's control. Readers are cautioned not to place undue reliance
on forward-looking statements. NBTY cannot guarantee future
results, trends, events, levels of activity, performance or
achievements. NBTY does not undertake and specifically declines any
obligation to update, republish or revise forward-looking
statements to reflect events or circumstances after the date hereof
or to reflect the occurrences of unanticipated events. DATASOURCE:
NBTY, Inc. CONTACT: Harvey Kamil, President and Chief Financial
Officer of NBTY, Inc.; or Carl Hymans of G.S. Schwartz & Co.,
+1-212-725-4500, , for NBTY, Inc. Web site: http://www.nbty.com/
Copyright
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 9월(9) 2024 으로 10월(10) 2024
N B T Y (NYSE:NTY)
과거 데이터 주식 차트
부터 10월(10) 2023 으로 10월(10) 2024